SARomics Biostructures and Red Glead Discovery Enters into Drug Discovery Collaboration
Thursday, October 25, 2012
The companies will perform a joint collaborative project with the goal of developing novel lead compounds against epigenetic pathway targets.
Thermo Fisher Scientific Reports Q3 Revenue and EPS Results
Wednesday, October 24, 2012
Revenue increased 5% to a record $3.09 billion for the third quarter with adjusted operating income rising 5% to $576 million.
BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge
Tuesday, October 23, 2012
New company to focus on oral drugs for hepatitis C and hereditary angioedema. Combined HCV portfolio includes three complementary viral targeting mechanisms.
The Crystal Structure of the Dess–Martin Periodinane
Tuesday, October 23, 2012
Researchers from Ludwig-Maximilians-Universität München have determined the solid-state structure of the Dess–Martin periodinane, a popular reagent in organic synthesis.
NIH Researchers Provide Detailed View of Brain Protein Structure
Monday, October 22, 2012
Results may help improve drugs for neurological disorders.
NovAliX Appoints CSO
Wednesday, October 17, 2012
Appointment of Dr Luc Van Hijfte as CSO drug discovery.
Biochemists Open Path for Possible Molecular ‘Chaperone’ Therapy
Tuesday, October 16, 2012
UMass scientists identify molecule that could help treat metabolic disorder.
NIH Researchers Provide Detailed View of Brain Protein Structure
Friday, October 12, 2012
Results may help improve drugs for neurological disorders.
Proteros Appoints New Chief Financial Officer
Wednesday, October 10, 2012
Mr Arnd Christ will be joining Proteros biostructures GmbH as Chief Financial Officer on 16th November.
|
|
|
|
|
|
